
Distinguished Scientist, Pharmacokinetics
Merck
Summary
The department of Pharmacokinetics, Dynamics, Metabolism and Bioanalytics (PDMB) is seeking a Distinguished Scientist to serve as Drug Metabolism and Pharmacokinetics (DMPK) submission expert. This leader will have broad responsibilities in support of our robust development pipeline to ensure consistent quality filings from FIH to marketing applications and through life-cycle management.
Job description
Key Responsibilities
- Monitor the progression of programs in late-stage development and post-marketing to ensure nonclinical packages in support of original marketing applications (OMA) and supplemental applications (sNDA) are robust, prepared timely, according to filing strategy and aligned with clinical safety and efficacy positions
- Represent PDMB in Label Approval Strategy Teams and in ad-hoc discussions/teams where DMPK expertise is required, such as Clinical Safety/Risk Management, nonclinical safety mechanistic investigations as they pertain to regulatory filings, ICH guidance or label updates
- Review investigator brochures, clinical trial applications, IND, NDAs, regulatory responses and other legal/scientific documents to support global clinical trials and registration
- Provide scientific and strategic oversight for development candidates across therapeutic areas through close collaboration with PDMB program representatives, subject-matter experts and management as well as key partners in other functional areas
- Actively contribute to discussions regarding Clinical Pharmacology strategy, including starting dose, dose escalation, timing, design and interpretation of Ph1 studies
- Ensuring DMPK data and documentation practices maintain quality in pace with changes in regulatory expectations across countries/regions
- Leading internal and cross-departmental initiatives to improve policies, procedures, and/or strategic direction
- Responsible for overseeing and/or conducting critical due diligence reviews for in-licensing assets across Therapeutic Areas and serve as integration lead
- Serve as program representative for high-priority development programs
- Contribute to the development of future leaders to build organizational experience in drug development, regulatory processes, risk assessments and regulatory guidelines
Education
PhD or M.Sci. in Pharmaceutical Sciences, Pharmacology or related field.
Required Experience and Skills
- Minimum experience of 15 years in DMPK with extensive experience as team representative in drug discovery and development programs
- Strong scientific acumen, as well as understanding of the drug development process and relevant regulatory guidelines, with a track-record of successful support of clinical candidates and first-in-human execution
- Previous experience collaborating with and mentoring program team representatives on an array of nonclinical and clinical issues
- Strong leadership skills and ability to work, collaborate with and influence scientists across a wide range of scientific disciplines
- Efficient organizational skills and excellent verbal and written communications
- Experience in authoring and critically reviewing nonclinical PK packages and clinical sections of relevant regulatory documents (IBs, INDs, CTAs, NDAs, BLAs, MAAs, PIP/PSPs, Scientific Advice, weight of evidence risk assessments, regulatory responses, product labels, etc.)
- Demonstrated experience navigating issues and regulatory requirements for advancing drug development candidates across modalities from preclinical through Phase 4 development, regulatory approvals and/or post-approval commitments
Preferred Experience and Skills
- Extensive experience in early development and product development teams
- Experience in Scientific Advisory Committee Meetings with the FDA and/or other regulatory agencies
- Deep understanding of filing and labeling requirements across major world markets
Requirements
- PhD or M.Sci. in Pharmaceutical Sciences, Pharmacology or related field
- Minimum experience of 15 years in DMPK
- Extensive experience as team representative in drug discovery and development programs
- Strong scientific acumen and understanding of the drug development process and relevant regulatory guidelines
- Track-record of successful support of clinical candidates and first-in-human execution
- Experience collaborating with and mentoring program team representatives on nonclinical and clinical issues
- Strong leadership skills and ability to influence scientists across scientific disciplines
- Efficient organizational skills and excellent verbal and written communications
- Experience authoring and critically reviewing nonclinical PK packages and clinical sections of regulatory documents (IBs, INDs, CTAs, NDAs, BLAs, MAAs, PIP/PSPs, Scientific Advice, regulatory responses, product labels)
- Demonstrated experience navigating regulatory requirements for advancing drug development candidates from preclinical through Phase 4
- Drug Development
- Drug Metabolism
- Pharmacokinetics
- Portfolio Strategies
- Regulatory Filings
- Regulatory Strategies
- Regulatory Submissions
- Scientific Leadership
- Small Molecules
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate Leave
- Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.